Cargando…
Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial
BACKGROUND: To investigate whether the administration of hydrogen/oxygen mixture was superior to oxygen in improving symptoms in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). METHODS: This prospective, randomized, double-blind, controlled clinical trial in 10 ce...
Autores principales: | Zheng, Ze-Guang, Sun, Wu-Zhuang, Hu, Jie-Ying, Jie, Zhi-Jun, Xu, Jin-Fu, Cao, Jie, Song, Yuan-Lin, Wang, Chang-Hui, Wang, Jing, Zhao, Hui, Guo, Zhong-Liang, Zhong, Nan-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120708/ https://www.ncbi.nlm.nih.gov/pubmed/33985501 http://dx.doi.org/10.1186/s12931-021-01740-w |
Ejemplares similares
-
Comparison of Immediate and Sequential Withdrawal of a Systemic Glucocorticoid in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Parallel-Controlled, Open-Label Study
por: Zhou, Ling, et al.
Publicado: (2021) -
Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial
por: Guan, Wei-Jie, et al.
Publicado: (2020) -
Erratum to hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial
por: Guan, Wei-Jie, et al.
Publicado: (2020) -
Pharmacokinetics and safety of IBI301 versus rituximab in patients with CD20(+) B-cell lymphoma: a multicenter, randomized, double-blind, parallel-controlled study
por: Jiang, Bo, et al.
Publicado: (2020) -
Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial
por: Zheng, Jin-ping, et al.
Publicado: (2023)